Skip to main content
. Author manuscript; available in PMC: 2025 Mar 15.
Published in final edited form as: J Pharm Biomed Anal. 2023 Dec 30;240:115932. doi: 10.1016/j.jpba.2023.115932

Table 7.

Clinical application of antiretroviral assays

Analyte Time after dose (hours) Curve Utilized Concentration (ng/mL)
Abacavira 1.8 High 4866
Bictegravirb 10.8 High 4825
Cabotegravir 984 High 2421
Dolutegravira 1.8 High 3072
Doravirine 11.6 High 1072
Emtricitabineb 10.8 High 1268
Lamivudinea 1.8 High 2236
Tenofovirb 10.8 Low 11.5

Superscript letters (a and b) represent samples from patients receiving combination antiretroviral therapy.